
0.598 BATS BZX Real-Time Price As of 12:13pm ET | ![]() Today’s Change | 0.28 Today|||52-Week Range 7.07 | -84.10% Year-to-Date |
Endo (ENDP) Phase II Study for Frozen Shoulder Disappoints Jul 04 / Zacks.com - Paid Partner Content | Why Endo (ENDP) Stock Wilted After its Surge on Tuesday? Jun 30 / Zacks.com - Paid Partner Content |
Previous close | 0.57 |
Today’s open | 0.66 |
Day’s range | 0.57 - 0.71 |
Volume | 1,738,127 |
Average volume (3 months) | 22,867,162 |
Market cap | $129.5M |
Earnings growth (last year) | -428.40% |
Earnings growth (this year) | -70.10% |
Earnings growth (next 5 years) | -10.20% |
Revenue growth (last year) | +3.10% |
P/E ratio | NM |
Price/Sales | 0.29 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
SCPHscPharmaceuticals In... | -0.01 | -0.20% |
---- | ||
FSTXF-Star Therapeutics ... | -0.04 | -0.64% |
CTXRCitius Pharmaceutica... | -0.01 | -1.19% |
Next reporting date | August 10, 2022 |
EPS forecast (this quarter) | -$0.02 |
Annual revenue (last year) | $3.0B |
Annual profit (last year) | -$613.2M |
Net profit margin | -19.01% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |